Cetera Investment Advisers’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,090
| Closed | -$644K | – | 4150 |
|
|
2025
Q1 | $644K | Sell |
10,090
-1,084
| -10% | -$69.2K | ﹤0.01% | 2635 |
|
|
2024
Q4 | $1.36M | Buy |
11,174
+463
| +4% | +$56.3K | ﹤0.01% | 1941 |
|
|
2024
Q3 | $1.34M | Sell |
10,711
-2,302
| -18% | -$287K | ﹤0.01% | 1904 |
|
|
2024
Q2 | $2.06M | Buy |
13,013
+1,022
| +9% | +$161K | ﹤0.01% | 1554 |
|
|
2024
Q1 | $1.55M | Buy |
11,991
+2,590
| +28% | +$335K | ﹤0.01% | 1744 |
|
|
2023
Q4 | $907K | Buy |
+9,401
| New | +$907K | 0.01% | 1153 |
|
|
2021
Q3 | – | Sell |
-3,561
| Closed | -$277K | – | 1854 |
|
|
2021
Q2 | $277K | Buy |
+3,561
| New | +$277K | ﹤0.01% | 1469 |
|
|
2021
Q1 | – | Sell |
-2,040
| Closed | -$348K | – | 1687 |
|
|
2020
Q4 | $348K | Buy |
+2,040
| New | +$348K | 0.01% | 1156 |
|